Company / Net Income
Moderna Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$2.8B
FY2025
5-year range
-$4.7B / -$514.0M
FY2021-FY2025
Trend
+20.8%
vs FY2024
Sector context
#215 of 216
Health Care
What the data says
Among 216 Health Care companies, Moderna is in the bottom 0% for net income. Net Income has fluctuated over the past 10 years, ranging from -$4.7B in FY2023 to -$216M in FY2016.
Based on SEC 10-K filings.
-$2.8B in FY2025.
Improved from -$4.7B to -$2.8B over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 216This company -$2.8B Sector average $454.3M
▼
-721.2% below sector average
Key checks
Key Insights
- In FY2025, net income increased 20.8% year-over-year.
- Ranks #215 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2016.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.8B | +20.8% |
| FY2024 | -$3.6B | +24.5% |
| FY2023 | -$4.7B | -531.1% |
| FY2022 | -$747.0M | -45.3% |
| FY2021 | -$514.0M | +31.2% |
| FY2020 | -$747.0M | -45.3% |
| FY2019 | -$514.0M | -33.6% |
| FY2018 | -$384.7M | -50.3% |
| FY2017 | -$255.9M | -18.4% |
| FY2016 | -$216.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026